306 related articles for article (PubMed ID: 26745002)
21. Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation.
Guo H; Zhang X; Cui Y; Deng W; Xu D; Han H; Wang H; Chen Y; Li Y; Wu D
Biochem Biophys Res Commun; 2014 Jul; 450(1):729-34. PubMed ID: 24950404
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension.
Nakamura K; Matsubara H; Akagi S; Sarashina T; Ejiri K; Kawakita N; Yoshida M; Miyoshi T; Watanabe A; Nishii N; Ito H
J Clin Med; 2017 Apr; 6(5):. PubMed ID: 28468233
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone Contributed to Pulmonary Arterial Hypertension Development via Stimulating Aquaporin Expression and Pulmonary Arterial Smooth Muscle Cells Proliferation.
Wang Y; Zhong B; Wu Q; Zhu T; Wang Y; Zhang M
Pharmacology; 2020; 105(7-8):405-415. PubMed ID: 31995798
[TBL] [Abstract][Full Text] [Related]
24. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
[No Abstract] [Full Text] [Related]
25. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT
Su H; Xu X; Yan C; Shi Y; Hu Y; Dong L; Ying S; Ying K; Zhang R
Respir Res; 2018 Dec; 19(1):254. PubMed ID: 30547791
[TBL] [Abstract][Full Text] [Related]
26. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
27. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
[TBL] [Abstract][Full Text] [Related]
29. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
Xiao Y; Gong D; Wang W
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
[TBL] [Abstract][Full Text] [Related]
31. Berberine alleviates pulmonary hypertension through Trx1 and β-catenin signaling pathways in pulmonary artery smooth muscle cells.
Wande Y; Jie L; Aikai Z; Yaguo Z; Linlin Z; Yue G; Hang Z
Exp Cell Res; 2020 May; 390(1):111910. PubMed ID: 32147507
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
[TBL] [Abstract][Full Text] [Related]
34. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
35. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Li Q; Wang J; Zhu X; Zeng Z; Wu X; Xu Y; Xie J; Yu J
Biomed Pharmacother; 2017 Dec; 96():825-833. PubMed ID: 29078260
[TBL] [Abstract][Full Text] [Related]
36. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Masson B; Le Ribeuz H; Sabourin J; Laubry L; Woodhouse E; Foster R; Ruchon Y; Dutheil M; Boët A; Ghigna MR; De Montpreville VT; Mercier O; Beech DJ; Benitah JP; Bailey MA; Humbert M; Montani D; Capuano V; Antigny F
Circ Res; 2022 Oct; 131(9):e102-e119. PubMed ID: 36164973
[TBL] [Abstract][Full Text] [Related]
37. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
[TBL] [Abstract][Full Text] [Related]
38. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
Akagi S; Nakamura K; Matsubara H; Kusano KF; Kataoka N; Oto T; Miyaji K; Miura A; Ogawa A; Yoshida M; Ueda-Ishibashi H; Yutani C; Ito H
Int J Cardiol; 2013 May; 165(3):499-505. PubMed ID: 21955608
[TBL] [Abstract][Full Text] [Related]
40. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.
Zhou L; Chen Z; Vanderslice P; So SP; Ruan KH; Willerson JT; Dixon RA
Circulation; 2013 Aug; 128(9):982-94. PubMed ID: 23841984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
